Product Images Pregabalin

This is a description of a medication called "Pregabalin Capsules" which contains 300mg of Pregabalin. It is available in a bottle of 60 capsules and the NDC number is 71335-1505-01. The medication is prescription-only and should be kept away from children. The capsules must be stored in a temperature-controlled environment at 20° to 25° C (68° to 77° F), with excursions allowed to 15° to 30° C (59° to 86° F).*

This is a drug packaging label, which compares the contents with Lyrica 300mg (CV) Capsule manufactured by Laurus Labs Limited. The package was prepacked by Bryant Ranck Prepack and contains 60 capsules. The NDC number is 7133515051 and the expiration date is mentioned. The label also includes the address of the manufacturer and storage conditions for the medication. The last sequence of numbers might be a barcode or reference number.*

This appears to be a table showing percentage improvement in pain for patients taking "Pregabalin 160 mg frse tne 3 day". However, some of the text is garbled and difficult to interpret, and there is no clear heading or context for the table. So a specific description cannot be provided.*

This appears to be a table showing the dosage of two medications, pregabalin and placebo, for pain relief. It also includes data on the percentage of patients who improved and the percentage of improvement in pain from baseline. However, the information is not well formatted and some characters are unclear, possibly due to errors.*

Not available. The provided text seems to be a mix of random characters and codes, rather than an actual readable description of something.*

This appears to be a table showing different dosage amounts of Pregabalin and Placebo, as well as the percentage of patients and their corresponding percent improvement in pain from baseline. The dosages listed are 450mg/day and 100mg/day for Pregabalin, and there is a misspelling of "Pregabalin" in the first line. However, without further context or information it is difficult to provide a more detailed description or interpretation.*

This text is not available as it consists of some random characters and symbols.*

The text represents a table with the title "Percent Improved from Baseline to Week 16 BOCF" showing the percentage of subjects who improved under the treatments of Pregabalin and Placebo. The percentages range from 100 to 280, and the table includes numbers ranging from 210 to 270, with a value of 200 at the endpoint.*